Search

everythinglearnresearchcommunity

for

Search:↓

Steroid-binding globulins have important roles beyond just transporting steroids.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

SHBG binding properties are unchanged in male liver cirrhosis patients.

SHBG may be a useful early indicator and treatment target for PCOS.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Birth control pills can help reduce mild to moderate acne in women.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Spironolactone treatment increases the amount of testosterone available in the body.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Adjuvants, diet changes, and laser therapy may improve male pattern hair loss.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.